For PAH Treatment, Extended-Release Ralinepag Shows Positive Phase 1 Results

  • For PAH Treatment, Extended-Release Ralinepag Shows Positive Phase 1 Results

    Posted by Community Member on September 3, 2018 at 7:49 am

    Extended-release ralinepag, a treatment candidate for pulmonary arterial hypertension, showed benefits over immediate-release medications in Phase 1 trials.

    Click here to read more about this story.

    What are your thoughts on this news?

    replied 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.